Acute Lymphoblastic Leukemia: Risk Stratification
1 vistas
administrator
06/15/23
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.
Mostrar más
Comentarios de Facebook
No se encontraron comentarios